Company Filing History:
Years Active: 2004-2019
Title: Hui-Quan Han: Innovator in Muscle-Wasting Treatments
Introduction
Hui-Quan Han is a prominent inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of biotechnology, particularly in developing treatments for muscle-wasting diseases. With a total of 14 patents to his name, Han's work has the potential to impact many lives.
Latest Patents
One of Han's latest patents involves the development of variant activin IIB soluble receptor polypeptides and proteins. These innovative proteins are capable of binding and inhibiting the activities of activin A, myostatin, or GDF-11. The invention also includes polynucleotides, vectors, and host cells that can produce these variant polypeptides and proteins. Furthermore, the patent outlines compositions and methods for treating muscle-wasting and other related diseases and disorders.
Career Highlights
Throughout his career, Hui-Quan Han has worked with notable companies such as Amgen Inc. and Atara Biotherapeutics, Inc. His experience in these organizations has allowed him to refine his expertise in biotechnology and contribute to groundbreaking research.
Collaborations
Han has collaborated with several talented individuals in his field, including Keith Soo-Nyung Kwak and Xiaolan Zhou. These partnerships have fostered innovation and have been instrumental in advancing his research.
Conclusion
Hui-Quan Han is a distinguished inventor whose work in developing treatments for muscle-wasting diseases showcases his dedication to improving health outcomes. His innovative patents and collaborations highlight his significant contributions to biotechnology.